Suitability of Exoseal Vascular Closure Device for Antegrade Femoral Artery Puncture Site Closure

Christopher Schmelter,Andrea Liebl,Nektarios Poullos,Volker Ruppert,Dierk Vorwerk
DOI: https://doi.org/10.1007/s00270-012-0501-2
2012-10-17
CardioVascular and Interventional Radiology
Abstract:PurposeTo assess the efficacy and safety of the Exoseal vascular closure device for antegrade puncture of the femoral artery.MethodsIn a prospective study from February 2011 to January 2012, a total of 93 consecutive patients received a total of 100 interventional procedures via an antegrade puncture of the femoral artery. An Exoseal vascular closure device (6F) was used for closure in all cases. Puncture technique, duration of manual compression, and use of compression bandages were documented. All patients were monitored by vascular ultrasound and color-coded duplex sonography of their respective femoral artery puncture site within 12 to 36 h after angiography to check for vascular complications.ResultsIn 100 antegrade interventional procedures, the Exoseal vascular closure device was applied successfully for closure of the femoral artery puncture site in 96 cases (96 of 100, 96.0 %). The vascular closure device could not be deployed in one case as a result of kinking of the vascular sheath introducer and in three cases because the bioabsorbable plug was not properly delivered to the extravascular space adjacent to the arterial puncture site, but instead fully removed with the delivery system (4.0 %). Twelve to 36 h after the procedure, vascular ultrasound revealed no complications at the femoral artery puncture site in 93 cases (93.0 %). Minor vascular complications were found in seven cases (7.0 %), with four cases (4.0 %) of pseudoaneurysm and three cases (3.0 %) of significant late bleeding, none of which required surgery.ConclusionThe Exoseal vascular closure device was safely used for antegrade puncture of the femoral artery, with a high rate of procedural success (96.0 %), a low rate of minor vascular complications (7.0 %), and no major adverse events.
radiology, nuclear medicine & medical imaging,cardiac & cardiovascular systems
What problem does this paper attempt to address?